Race Financial Statements From 2010 to 2025
| RAONFDelisted Stock | USD 1.22 0.00 0.00% |
Check Race Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Race Oncology's main balance sheet or income statement drivers, such as , as well as many indicators such as . Race financial statements analysis is a perfect complement when working with Race Oncology Valuation or Volatility modules.
Race |
Race Oncology Limited Company Return On Equity Analysis
Race Oncology's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Race Oncology Return On Equity | -0.45 |
Most of Race Oncology's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Race Oncology Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Race Oncology Limited has a Return On Equity of -0.4496. This is 98.12% lower than that of the Healthcare sector and 98.77% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 45.03% higher than that of the company.
Race Oncology Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Race Oncology's current stock value. Our valuation model uses many indicators to compare Race Oncology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Race Oncology competition to find correlations between indicators driving Race Oncology's intrinsic value. More Info.Race Oncology Limited is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Race Oncology's earnings, one of the primary drivers of an investment's value.About Race Oncology Financial Statements
Race Oncology stakeholders use historical fundamental indicators, such as Race Oncology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Race Oncology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Race Oncology's assets and liabilities are reflected in the revenues and expenses on Race Oncology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Race Oncology Limited. Please read more on our technical analysis and fundamental analysis pages.
Race Oncology Limited operates as a precision oncology company in Australia. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia. Race Oncololgy operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Race Pink Sheet
If you are still planning to invest in Race Oncology Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Race Oncology's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |